IRB Barcelona logo

News

Highlighting IRB Barcelona's impact on society

News

Institutional
The 2019 IRB Barcelona Alumni Excellence Award goes to Ana Janic
Innovation
Ona Therapeutics, a start -up with great potential
Structure of a blood vessel. Raquel Batlle, IRB Barcelona.
Scientific - Nature Communications
A study demonstrates that p38 protein regulates the formation of new blood vessels in tumours
Proliferative and invasive capacity of tumour cells (centre) compared to normal cells (left) and effect of TRAMETINIB treatment, which reduces the invasive capacity and tumoural load (right). Marco Milán, IRB Barcelona.
Scientific
Researchers at IRB Barcelona manage to selectively eliminate cells that express the oncogene RAS, which is present in 30% of human cancers
The DNAzyme 9DB1, whose catalytically active structure and reaction mechanism was unknown, makes use of a mechanism involving two ions, similar to that used by natural enzymes (J. Aranda, IRB Barcelona).
Scientific
A study from IRB Barcelona describes the reaction mechanism of DNAzymes and opens new propsects in the field of biocatalysers
Scientific - Published in Chem
A study makes a significant contribution to progress in gene therapy efficiency by identifying the source of asymmetry in RNA · DNA hybrids
The androgen receptor helix of polyglutamine becomes increasingly stable as the number (n) of glutamine amino acid residues increases.
Scientific
Researchers at IRB Barcelona discover the structural consequences of the mutation that causes Kennedy disease
Innovation
#WeAreIRB: “The Drug Discovery Journey” by Israel Ramos, IRB Barcelona Technology Transfer Consultant
Illustrated view of the different conformations adopted by a flexible small molecule. Colours represent different ensembles of conformations.
Scientific
Molecular dynamics simulation provides a “single-interaction” perspective to protein dynamics and drug binding

Media Mentions

Blog

Do you want to be informed?

Visit our blog.

IRB Blog